Introduction Obstructive sleep apnoea (OSA) is a prevalent disease associated with
cardiovascular events. Hypertension is one of the major intermediary mechanisms leading …

Obstructive sleep apnoea (OSA) is associated with cardiovascular morbidity and may
precipitate cardiac dysrhythmias. Uncontrolled reports suggest that continuous positive …

Background: Increased daytime blood pressure variability (BPV) is associated with
cardiovascular risk. Preliminary data suggest that obstructive sleep apnoea (OSA) might …

Purpose Non-invasive measurements of arterial stiffness including the augmentation index
(AIx) and central blood pressure (BP) have been used to assess the cardiovascular health of …

Obstructive sleep apnoea (OSA) is associated with high cardiovascular morbidity and
mortality. Several randomised controlled trials have shown that continuous positive airway …

Introduction: Obstructive sleep apnoea (OSA) is highly prevalent and there is considerable
evidence supporting an independent association with a wide range of co-morbidities …

Background: Obstructive sleep apnoea (OSA) is associated with high cardiovascular
morbidity and mortality. Randomised controlled trials have shown that, on average …

Background A strong association between obstructive sleep apnea (OSA) and the risk for
cardiovascular and cerebrovascular diseases has been reported. Continuous positive …

Obstructive Sleep Apnoea (OSA) is a common sleep-related breathing disorder,
characterised by repeated interruptions in breathing while asleep due to collapse of the …

Continuous positive airway pressure (CPAP) reduces blood pressure in obstructive sleep
apnoea (OSA) patients, as well as in patients with resistant hypertension. The effect of CPAP …